FDA Warns IBS Drug Viberzi May Cause Pancreatitis In Patients Without Gallbladder

(March 17, 2017, 8:35 AM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on March 15 issued a drug safety communication warning that the irritable bowel syndrome (IBS) drug Viberzi has been associated with reports of hospitalizations and deaths in patients who do not have a gallbladder....

Related Sections